Lars Björck

Lars Björck is a Professor and Associate Professor in Infection Medicine at Lund University’s Faculty of Medicine, affiliated with the BMC (Clinical Sciences Lund) campus. He serves as a Project Manager for Molecular Pathogenesis and a researcher in the epIgG and Infect@LU research groups. His work focuses on bacterial pathogenesis, immune modulation, and infectious disease mechanisms. Key research areas include Streptococcus pyogenes proteinases (e.g., IdeS), antibody interactions, and bacterial evasion of host immune responses.

Research interests span bacterial protein function, antibody inactivation mechanisms, and vaccine development. His projects include studying immune modulating proteins (SIC and IdeS) and developing monoclonal antibodies against streptococcal pathogens. He has contributed to over 135 research outputs, with recent work emphasizing Streptococcal proteins’ roles in immune evasion and inflammatory responses.

Lars Björck has led major projects such as the Hygieia initiative, a collaborative effort to develop strategies for infectious disease prevention and treatment. His research bridges molecular biology, immunology, and clinical applications, with a focus on translating findings into therapeutic solutions for infectious diseases.